<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1) is a potential therapeutic target for <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e>, but its role in <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> remains controversial </plain></SENT>
<SENT sid="1" pm="."><plain>Whereas germline Vegfr-1(-/-) embryos die of <z:mp ids='MP_0000259'>abnormal vascular development</z:mp> in association with excessive endothelial differentiation, mice lacking only the kinase domain appear healthy </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: We performed Cre-loxP-mediated knockout to abrogate the expression of <z:hpo ids='HP_0000001'>all</z:hpo> known VEGFR-1 functional domains in neonatal and adult mice and analyzed developmental, pathophysiological, and molecular consequences </plain></SENT>
<SENT sid="3" pm="."><plain>VEGFR-1 deficiency promoted tip cell formation and endothelial cell proliferation and facilitated <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> of blood vessels that matured and perfused properly </plain></SENT>
<SENT sid="4" pm="."><plain>Vascular permeability was <z:mpath ids='MPATH_458'>normal</z:mpath> at the basal level but elevated in response to high doses of exogenous VEGF-A </plain></SENT>
<SENT sid="5" pm="."><plain>In the postinfarct ischemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> model, VEGFR-1 deficiency supported robust <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> and protected against <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>VEGFR-1 knockout led to abundant accumulation of VEGFR-2 at the protein level, increased VEGFR-2 tyrosine phosphorylation transiently, and enhanced serine phosphorylation of Akt and ERK </plain></SENT>
<SENT sid="7" pm="."><plain>Interestingly, <z:mp ids='MP_0005601'>increased angiogenesis</z:mp>, tip cell formation, vascular permeability, VEGFR-2 accumulation, and Akt phosphorylation could be partially rescued or suppressed by one or more of the following manipulations, including injection of the VEGFR-2 selective inhibitor SU1498, anti-VEGF-A, or introduction of Vegfr-2(+/-) heterozygosity into Vegfr-1 somatic knockout mice </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Upregulation of VEGFR-2 abundance at the protein level contributes in part to <z:mp ids='MP_0005601'>increased angiogenesis</z:mp> in VEGFR-1-deficient mice </plain></SENT>
</text></document>